Everything tagged "de spac" across research, earnings, and macro.
11 articles
newcleo, the advanced nuclear company developing lead-cooled fast reactors and MOX fuel, is going public via a merger with NewHold Investment Corp. III (Nasdaq: NHIC). The deal values newcleo at about $2.4 billion pre-money and could bring in roughly $429 million before redemptions, but the setup still carries heavy execution, regulatory, and dilution risk.
Marine Thinking, a Halifax-based autonomous marine technology company, is going public through a merger with Eureka Acquisition Corp (NASDAQ: EURK). The setup offers exposure to early-stage maritime autonomy, but shareholders should watch the limited customer base, early commercialization, and de-SPAC dilution risks.
IQM Quantum Computers is a Finland-based superconducting quantum hardware company going public via a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ), with the deal still working through SEC and shareholder-approval steps. The setup has real revenue and a large PIPE behind it, but investors should watch redemption risk, dilution, and whether the trust cash survives intact.
KIKA Technology is a Hong Kong ad-tech and software company going public via merger with Wintergreen Acquisition Corp. (WTG), with the deal still pending as of the latest SEC filing. The bull case is a small, focused digital advertising platform; the bear case is redemption pressure, dilution, and a modest operating base.
OpenPayd, a global financial infrastructure platform for programmable money movement, is going public through a merger with Titan Acquisition Corp. (NASDAQ: TACH). The bull case is a fast-growing fintech tied to stablecoin-enabled payments; the bear case is valuation, dilution, and redemption risk before the deal closes.
StableCoinX is going public by merging with TLGY Acquisition Corp., the SPAC that traded under TLGY before the deal closed. The combined company began trading on Nasdaq as USDE on June 26, 2026, and the setup hinges on whether investors buy the Ethena-linked growth story despite heavy dilution and crypto risk.
Vesicor Therapeutics, a preclinical oncology gene-therapy company, is going public via merger with Black Hawk Acquisition Corp (BKHA). The deal is still pending in the latest June 2026 filing, and the setup hinges on whether redemptions and dilution leave enough capital for a real biotech runway.
Old Glory Bank is a digital-first, FDIC-insured bank focused on personal and small-business banking, and it is going public through a merger with Digital Asset Acquisition Corp. (DAAQ), with closing expected in Q2 2026. The setup is attractive if you believe in the brand-led growth story, but shareholders should watch redemption risk, dilution from warrants, and whether the financing package actually lands as disclosed.
Goodvision AI is a cloud-computing and AI-infrastructure company going public through a merger with Calisa Acquisition Corp. (NASDAQ: ALIS), with the deal expected to close in the second half of 2026. The bull case is exposure to AI inference infrastructure; the bear case is redemption risk, dilution, and execution risk before the business is public.
MicroTouch Technology is an IT services and ad-tech matching company going public through a merger with Future Vision II Acquisition Corp. (Nasdaq: FVN). The deal is still in SEC review, and the key question is whether redemptions, dilution, and listing approval leave enough cash and momentum for the combined company to trade well after closing.
General Fusion, the Vancouver-based fusion-energy company founded in 2002, is going public through a merger with Spring Valley Acquisition Corp. III (SVAC). The deal is expected to close shortly after the July 6, 2026 shareholder vote if approved. The setup is high-upside but still early-stage: investors should watch valuation, redemptions, and dilution more than the headline fusion story.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator